Browse the full Event Guide to discover:

• NAVIGATE the multi-layered regulatory frameworks that require both EMA and country-specific legislation
• DISCOVER how leading companies are successfully planning, running, closing and reimbursing access programmes across Europe
• ANSWER your burning questions around drug supply, regulatory harmonisation, and real-world evidence collection
• BUILD your understanding of the current challenges around reimbursement, integrating of pre- and post-trial access programmes and scoping
• ENGAGE with your community and peers from leading pharma and biotech companies to build lasting connections, complementary collaborations and improving patient access to life saving drugs